ClinicalTrialsFinder

Focal segmental glomerulosclerosis (FSGS) Clinical Trials in Tianjin, Hebei

1 recruitingTianjin, Hebei, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Focal segmental glomerulosclerosis (FSGS)IgA Nephropathy (IgAN)Minimal Change Disease (MCD)
Everest Medicines (China) Co.,Ltd.45 enrolled2 locationsNCT07614477